Videos

Dr. Onikepe Owolabi emphasizes redefining family planning need through women’s expressed demand, urging policymakers to prioritize adolescent access and last‑mile services in humanitarian contexts. 

Advocates spotlight the escalating erosion of reproductive rights in the US since Dobbs, documenting human costs and urging accountability.

At the International Population Conference, Guttmacher shared new research on family planning’s economic impact, global contraceptive access losses and innovative studies expanding safe abortion care in Ethiopia.

This video calls for inclusive, rights‑based health data and highlights the urgent need to measure sexual health comprehensively to strengthen universal health coverage and advance bodily autonomy worldwide. 

Destiny Lopez of the Guttmacher Institute reflects on the post‑Dobbs landscape, highlighting rising abortion bans, increased interstate travel for care and ongoing efforts to defend reproductive freedom.

Jonathan Wittenberg (Co-President and CEO) highlights why measuring SRHR data is essential to expose hidden needs, challenge stigma and ensure government accountability for real experiences.

Sydney Jemmot (Director of Policy, Reproductive Rights) at State Innovation Exchange) and Kimya Forouzan detail five major trends in US SRHR policy, including abortion bans, youth restrictions, maternal health, fertility care and contraception access. 

Abortion rights and transgender rights intersect, highlighting overlapping bans, shared political agendas and the stakes of the US Supreme Court case US v. Skrmetti. 

Rep. Grace Meng questions Sen. Marco Rubio on canceling international family planning programs that save lives and prevent unsafe abortions, as Rubio confirms there is no plan to allocate the $575M Congress mandated.

Guttmacher staff outlines state bills like Arkansas’ ‘Meet Baby Olivia’ law and West Virginia’s ‘Don’t Say Gay’ bill distort sex education, replacing facts with stigma and disinformation.

Rep. Diana DeGette cites Guttmacher data showing FQHCs would need a 56% capacity increase to replace Planned Parenthood, warning that proposed cuts to Medicaid and Title X threaten birth control access for millions. 

Amy Friedrich-Karnik (Director of Federal Policy) explains why protecting Medicaid is critical for sexual and reproductive health, highlighting its role in reducing racial disparities and ensuring access to family planning for millions. 

Anna Bernstein, Principal Federal Policy Advisor, marks 100 days of the Trump administration, detailing actions undermining SRHR—from Title X cuts and trans health restrictions to dismantling USAID and ending global family planning aid. 

Krystal Leaphart (Senior Policy Associate, State Partnerships) highlights state-level wins for maternal health, including Michigan’s Birth Justice bill and efforts to expand IVF and doula coverage, while stressing the need for comprehensive SRHR access. 

Guttmacher expert analyzes state-level efforts to restrict medication abortion by classifying mifepristone and misoprostol as controlled substances, increasing barriers to care and criminalization risks. 

Irum Taqi, former Director of Global Policy at the Guttmacher Institute, emphasizes the cost-effectiveness of investing in SRHR and warns that Trump administration cuts to global health assistance threaten progress toward sustainable development and equality. 

Guttmacher’s Monthly Provision Study highlights the importance of medication abortion in the US.

Amy Friedrich-Karnik, Director of Federal Policy, explains what’s at stake in Medina v. Planned Parenthood South Atlantic, a Supreme Court case that could block Medicaid recipients from accessing care at Planned Parenthood health centers.

Elizabeth Sully (Director of International Research), Susana Chavez (Executive Secretary, CLACAI), Jonathan Bearak (Principal Research Scientist, Irum Taqi (former Director of Global Policy) and Jonathan Wittenberg (Co-President and CEO) stress the importance of data and research in defending SRHR amid disinformation, opposition and global challenges. 

Destiny Lopez (Co-President and CEO) reflects on how abortion storytelling shifted the movement, driving policy wins and cultural change by bringing abortion out of the shadows.

Destiny Lopez (Co-President and CEO) emphasizes that medication abortion now accounts for the majority of US abortions, urges envisioning a future where people can access abortion care in the way and place they choose and calls for bold thinking beyond fear and uncertainty. 

Experts from Guttmacher joined representatives from SIECUS: Sex Ed for Social Change, the National Black Justice Coalition and PEN America to explore cross-movement opportunities to protect and advance sexual and reproductive freedom. 

Maddow-Zimet’s testimony leveraged Guttmacher’s estimates of the number of people who traveled out of state for abortion care in 2023, calling for policies that support people’s right to and ability to cross state lines in the wake of bans and restrictions. 

Lopez’s testimony used Guttmacher’s latest research to highlight the shifting landscape of abortion access, calling on policymakers to champion a bold vision of abortion care that goes beyond what Roe promised.